CPAP improves endothelial function in patients with minimally symptomatic OSA: Results from a subset study of the MOSAIC trial

Chest

Volumn 144, Issue 3, 2013, Pages 896-902

  Kohler, Malcolm ^a,b   Craig, Sonya ^b   Pepperell, Justin C T ^c   Nicoll, Debby ^b   Bratton, Daniel J ^d   Nunn, Andrew J ^d   Leeson, Paul ^e   Stradling, John R ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c MUSGROVE PARK HOSPITAL   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERIAL STIFFNESS; ARTERY DILATATION; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE SEVERITY; ENDOTHELIAL FUNCTION; EPWORTH SLEEPINESS SCALE; FEMALE; FLOW MEDIATED DILATATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OXYGEN DESATURATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDERED BREATHING;

EID: 84884321214     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-0179     Document Type: Article

References (32)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002 ; 165 (9): 1217-1239.
2. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med. 2002 ; 166 (2): 159-165.
3. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol. 2010; 7(12): 677-685.
4. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995 ; 96 (4): 1897-1904.
5. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002 ; 105 (21): 2462-2464.
6. Ip MSM, Tse HF, Lam B, Tsang KWT, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004 ; 169 (3): 348-353.
7. Ross R. Atherosclerosis-an infl ammatory disease. N Engl J Med. 1999 ; 340 (2): 115-126.
8. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol. 1999 ; 31 (1): 23-37.
9. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 ; 340 (8828): 1111-1115.
10. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000; 101(16): 1899-1906.
11. Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002 ; 359 (9302): 204-210.
12. Kohler M, Pepperell JCT, Casadei B, et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J. 2008 ; 32 (6): 1488-1496.
13. Kohler M, Craig S, Nicoll D, Leeson P, Davies RJ, Stradling JR. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med. 2008 ; 178 (9): 984-988.
14. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J. 2006 ; 27 (6): 1229 - 1235.
15. Craig SE, Kohler M, Nicoll D, et al. Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial. Thorax. 2012 ; 67 (12): 1090-1096.
16. Monasterio C, Vidal S, Duran J, et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med. 2001 ; 164 (6): 939-943.
17. Barbé F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med. 2001 ; 134 (11): 1015-1023.
18. Barbé F, Durán-Cantolla J, Capote F, et al ; Spanish Sleep and Breathing Group. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010 ; 181 (7): 718-726.
19. Pitson DJ, Stradling JR. Autonomic markers of arousal during sleep in patients undergoing investigation for obstructive sleep apnoea, their relationship to EEG arousals, respiratory events and subjective sleepiness. J Sleep Res. 1998 ; 7 (1): 53-59.
20. Argod J, Pépin JL, Lévy P. Differentiating obstructive and central sleep respiratory events through pulse transit time. Am J Respir Crit Care Med. 1998 ; 158 (6): 1778-1783.
21. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 ; 14 (6): 540-545.
22. Bennett LS, Stradling JR, Davies RJ. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res. 1997 ; 6 (2): 142-145.
23. Pocock SJ, McCormack V, Gueyffi er F, Boutitie F, Fagard RH, Boissel JP. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ. 2001 ; 323 (7304): 75-81.
24. Kelly RP, Hayward CS, Avolio AP, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989 ; 80 (6): 1652-1659.
25. Weber T, Auer J, O'Rourke MF, et al. Arterial stiffness, wave refl ections, and the risk of coronary artery disease. Circulation. 2004 ; 109 (2): 184-189.
26. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratifi cation for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002 ; 105 (13): 1567-1572.
27. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of fl ow-mediated dilation to anklebrachial pressure index. Circulation. 2003; 108(17): 2093-2098.
28. Kohler M, Stoewhas AC, Ayers L, et al. The effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med. 2011 ; 184 (10): 1192-1199.
29. Cross MD, Mills NL, Al-Abri M, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax. 2008 ; 63 (7): 578-583.
30. Edwards DG, Schofi eld RS, Magyari PM, Nichols WW, Braith RW. Effect of exercise training on central aortic pressure wave refl ection in coronary artery disease. Am J Hypertens. 2004 ; 17 (6): 540-543.
31. Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens. 2006 ; 19 (2): 214-219.
32. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007 ; 176 (7): 706-712.